November 18, 2022 TRiNDS Team Spotlight: Sarah MacCallum, Clinical Project Lead All of us at TRiNDS come to work every day committed to conducting the best quality rare disease and neuromuscular research. Today we’d like to highlight Sarah MacCallum, Clinical Project Lead. We sat down with Sarah to learn more about her and her work…. Read more »
Year: 2022
TRiNDS Fall Retreat 2022 Highlights
October 26, 2022 TRiNDS Fall Retreat 2022 Highlights TRiNDS partners with innovative clients working in rare disease research around the world. We prioritize providing clients with high quality, uninterrupted support from our experienced and professional team members. To provide our clients with continuous support, TRiNDS fosters a predominantly work from home (WFH) environment that is… Read more »
TRiNDS Clinical Operations Services
September 22, 2022 TRiNDS Clinical Operations Services Behind every successful clinical trial is an efficient and skilled clinical operations team. Clinical operations teams need to be competent in several areas to be successful. From trial management, to clinical trial site selection and start-up, to ethical committee review supervision, these teams need to be able… Read more »
TRiNDS Strategic Solutions: Specialized Services for Specialized Research
August 12, 2022 TRiNDS Strategic Solutions: Specialized Services for Specialized Research TRiNDS Strategic Solutions are the specialty services we offer to help clients successfully complete high-quality, rare neuromuscular disease (NMD) clinical trials. Our Strategic Solutions includes Data and Safety Monitoring Board (DSMB), Genetic Confirmation, Study Measurements, and Community Engagement services. Oftentimes, our clients’ first experience… Read more »
TRiNDS Team Spotlight: Ana Christensen, Director of Strategic Solutions
July 11, 2022 TRiNDS Team Spotlight: Ana Christensen, Director of Strategic Solutions All of us at TRiNDS come to work every day committed to conducting the best quality rare disease and neuromuscular research. Today we’d like to highlight Ana Christensen, our Director of Strategic Solutions. We sat down with Ana to learn more about her… Read more »
Addressing Bias in Clinical Research
June 17, 2022 In the United States, we celebrate Juneteenth National Independence Day and LGBTQIA+ Pride Month in June. TRiNDS reflects each year upon the need to combat racism and anti- LGBTQIA+ bias in our work to support high quality clinical research to rare neuromuscular disease communities. The history of clinical research in the US… Read more »
TRiNDS and Working From Home: The Importance of Workplace Flexibility
May 3, 2022 TRiNDS and Working From Home: The Importance of Workplace Flexibility TRiNDS partners with innovative clients conducting rare neuromuscular disease research around the world. Our priority is to give clients high level, continuous support from specialized, experienced, and knowledgeable teams. One of the keys to a successful trial is retention of a qualified… Read more »
TRiNDS Team Spotlight: Diana Cunningham, Director of Data Management
April 6, 2022 TRiNDS Team Spotlight: Diana Cunningham, Director of Data Management All of us at TRiNDS come to work every day committed to conducting the best quality rare disease and neuromuscular research. Today we’d like to introduce Diana Cunningham, our Director of Data Management. We sat down with Diana to learn more about her… Read more »
TRiNDS Continuing Education Program: Investing in Excellence
March 2, 2022 TRiNDS Continuing Education Program: Investing in Excellence TRiNDS partners with innovative clients working in rare disease research. One of the keys to our success is our commitment to maintaining a culture of excellence. Our specialized, experienced, and knowledgeable teams of experts need to bring high level support to every project, every day…. Read more »
Genetic Confirmation: A Step You Can’t Afford to Get Wrong
February 2, 2022 Genetic Confirmation: A Step You Can’t Afford to Get Wrong Neuromuscular disorders (NMDs) are frequently caused by genetic mutations. However, the genetic causes of Duchenne muscular dystrophy (DMD), Spinal Muscular Atrophy (SMA), and other rare NMDs are often difficult to interpret due to differences in laboratory reporting, evolving genetics technology, and complex… Read more »
Improving the Participant Experience
January 5, 2022 Improving the Participant Experience TRiNDS is dedicated to providing contract research services to rare neuromuscular disease research around the world. We bring specialized processes, expert teams, and strong relationships to every trial we support. We focus on rare neuromuscular disorder research because it’s what we do best, and it’s what patients and… Read more »
